ADAGE CAPITAL PARTNERS GP, L.L.C.
Position in TNGX — Tango Therapeutics, Inc.
CIK 1165408
Boston, MA
Position in TNGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$175,056,000
-$92,918,426 QoQ
Shares Held
5,600,000
-56.3% QoQ
Ownership
3.32%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#14
of 246 holders
Holding Since
Sep 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TNGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ADAGE CAPITAL PARTNERS GP, L.L.C. holds $4,240,035,723 across 126 Biotechnology names. TNGX ranks #4 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
10,349,328 | $366,262,717 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
1,015,480 | $339,972,549 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
393,964 | $195,693,737 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
This page
|
5,600,000 | $175,056,000 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
2,252,000 | $167,728,960 | |
| 6 | SYRE |
Spyre Therapeutics, Inc.
|
1,722,300 | $152,905,794 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
2,569,356 | $145,965,114 | |
| 8 | RPRX |
Royalty Pharma plc
|
2,500,000 | $140,175,000 |
All Filings in TNGX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $175,056,000 | 5,600,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $267,974,426 | 12,809,485 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $93,986,206 | 10,607,924 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $21,092,400 | 2,511,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $30,235,386 | 5,905,349 | Shares | Sole | 2025-08-14 | |
| 2024-09-30 | $17,665,386 | 2,294,206 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $19,684,287 | 2,294,206 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $18,215,995 | 2,294,206 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $33,660,000 | 3,400,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $19,759,633 | 1,754,852 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,950,404 | 1,189,881 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $4,707,139 | 1,191,681 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $8,700,000 | 1,200,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,620,000 | 1,000,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,530,000 | 1,000,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $7,580,000 | 1,000,000 | Shares | Sole | 2022-05-16 | |
| 2021-06-30 BCTG | — | 500,000 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 BCTG | — | 600,000 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 BCTG | — | 600,000 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 BCTG | — | 600,000 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||